trimethyloxamine has been researched along with Parkinson Disease in 4 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, CM | 1 |
| Quan, W | 1 |
| Zhou, Y | 1 |
| Niu, GY | 1 |
| Hong, H | 1 |
| Wu, J | 1 |
| Zhao, LP | 1 |
| Li, T | 1 |
| Cui, C | 1 |
| Zhao, WJ | 1 |
| Shen, YQ | 1 |
| Chen, SJ | 1 |
| Kuo, CH | 1 |
| Kuo, HC | 1 |
| Chen, CC | 1 |
| Wu, WK | 1 |
| Liou, JM | 1 |
| Wu, MS | 1 |
| Lin, CH | 1 |
| Tan, AH | 1 |
| Chong, CW | 1 |
| Lim, SY | 1 |
| Yap, IKS | 1 |
| Teh, CSJ | 1 |
| Loke, MF | 1 |
| Song, SL | 1 |
| Tan, JY | 1 |
| Ang, BH | 1 |
| Tan, YQ | 1 |
| Kho, MT | 1 |
| Bowman, J | 1 |
| Mahadeva, S | 1 |
| Yong, HS | 1 |
| Lang, AE | 1 |
| Chung, SJ | 1 |
| Rim, JH | 1 |
| Ji, D | 1 |
| Lee, S | 1 |
| Yoo, HS | 1 |
| Jung, JH | 1 |
| Baik, K | 1 |
| Choi, Y | 1 |
| Ye, BS | 1 |
| Sohn, YH | 1 |
| Yun, M | 1 |
| Lee, SG | 1 |
| Lee, PH | 1 |
4 other studies available for trimethyloxamine and Parkinson Disease
| Article | Year |
|---|---|
Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson's Disease Model Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dopaminergi | 2023 |
The Gut Metabolite Trimethylamine N-oxide Is Associated With Parkinson's Disease Severity and Progression.
Topics: Gastrointestinal Microbiome; Humans; Methylamines; Parkinson Disease; Severity of Illness Index | 2020 |
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Topics: Aged; Ceramides; Chromatography, Liquid; Cognitive Dysfunction; Constipation; Fatty Acids, Volatile; | 2021 |
Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease.
Topics: Biomarkers; Gastrointestinal Microbiome; Humans; Methylamines; Parkinson Disease | 2021 |